Epithelix · Est. 2006
EPITHELIX
Alternative in vitro solutions to animal experimentation for evaluating drugs in development and assessing the toxicity of chemical compounds on the human respiratory tract.
Epithelix Sarl provides alternative in vitro solutions to animal experimentation (NAM – Non-Animal Methodologies, and MPS – Micro Physiological Systems) for evaluating the effects of drugs in development and assessing the toxicity of chemical compounds on the human respiratory tract.
Featured Products
MucilAir™-HF
SmallAir™ (SA)
SmallAir™-HF
What We Supply
5 Product Categories
Testing Services
Testing Services
Testing Services
2
Resources
Learn More
Resources
3
About the Partner
More About Epithelix
Epithelix is a biotech company founded in March 2006 in Geneva, Switzerland, by experienced scientists from the University of Geneva with special expertise and know-how for in vitro reconstitutions of human and animal tissues. It is the European leading provider of in vitro reconstituted human respiratory tissues and related services.
Epithelix Macrophage kit. MucilAir™, SmallAir™ and AlveolAir™ can be co-cultured with primary alveolar resident macrophages, and are available as kits.
Homeostatic Tissue Technology
A unique technology keeping reconstituted tissues at a homeostatic state for a long period, resembling native tissue morphologically and functionally.
MucilAir™
The only human respiratory epithelium model able to remain fully differentiated and functional for more than one year, available in the US, Europe and Asia.
CRO Testing Services
Using its own commercialized products, Epithelix offers innovative in vitro testing services in its laboratory.
Clinical Research Projects
Active in research projects related to clinical therapeutic purposes for respiratory diseases such as cancers.
Award-Winning
Recognized for its scientific and commercial achievements with a number of national and international awards.